Kawasaki disease (KD) is an acute muhisystem vasculitis of unknown etiology that is associated with marked activation of T cells and monocyte/macrophages. Using a quantitative polymerase chain reaction (PCR) technique, we recently found that the acute phase of KD is associated with the expansion of T cells expressing the V/32 and V/38.1 gene segments. In the present work, we used a newly developed anti-V/32 monoclonal antibody (mAb) and studied a new group of KD patients to extend our previous PCR results. Immunofluorescence analysis confirmed that V/32-bearing T cells are selectively increased in patients with acute KD. The increase occurred primarily in the CD4 T cell subset. The percentages of V/32 + T cells as determined by mAb reactivity and flow cytometry correlated linearly with V/3 expression as quantitated by PCR. However, T cells from acute KD patients appeared to express proportionately higher levels of V/32 transcripts per cell as compared with healthy controls or convalescent KD patients. Sequence analysis of T cell receptor/3 chain genes of V/32 and V/38.1 expressing T cells from acute KD patients showed extensive junctional region diversity. These data showing polyclonal expansion of V/32 + and V/38 + T cells in acute KD provide additional insight into the immunopathogenesis of this disease.
K
awasaki disease (KD) 1 is an acute illness of early childhood characterized by fever, induration, and erythema of the hands and feet, inflammation of the mucous membranes, polymorphous skin rash, and cervical lymphadenopathy (1, 2) . As a complication of this muhisystem disease, coronary artery aneurysms or ectasia secondary to vasculitis develop in 15-25% of affected patients (3, 4) . In the United States, KD is currently the major cause of acquired heart disease in children. Although epidemiologic evidence strongly supports an infectious etiology for this disease, the causative agent is unknown.
KD is associated with marked activation of T cells and monocyte/macrophages, as well as increased production of IL-1/3, TNF-oe, and ID6 (for a review, see reference 5). The marked immune activation and production of cytokines are 1 Abbreviations used in this paper: KD, Kawasaki disease; SEB, staphylococcal enterotoxin B; TSST-1, toxic shock syndrome toxin 1. thought to play an important role in the pathogenesis of vascular endothelial cell injury during acute disease by eliciting proinflammatory and prothrombotic responses (6) . These immunologic features are characteristic of diseases that are caused by microbial toxins that act as superantigens to stimulate a large proportion of T cells expressing specific TCR/3 chain variable (V/3) gene segments (7) . In this regard, toxic shock syndrome, a disease with many clinical features similar to acute KD, is caused by staphylococcal toxic shock syndrome toxin 1 (TSST-1), a superantigen that induces the massive expansion, in vitro and in vivo, of V/32 + T cells (8) .
Using a quantitative PCR technique, we recently found that the acute but not the convalescent phase of KD is associated with the expansion of T cells expressing V/32 and V/38 gene segments (9) . In contrast, the T cell repertoire in patients with other febrile illnesses and exanthems did not undergo similar alterations (9) . These observations suggested that the T cell activation associated with KD is due to superantigenic stimulation. An important characteristic of such stimulation, however, is that the other variable elements (D/3, JB, Vow, Jo~) of the TCR are not generally involved in antigen recognition (7) . The present study was therefore carfled out to characterize the TCRjunctional diversity associated with the expansion of V~2 and V/~8 T cells during acute KD and to use a newly available anti-V~2 mAb to extend our previous PCR studies.
Materials and Methods
Patients. 23 patients with KD (mean age, 38 too; range, 10 mo-7 yr, 6 mo) were studied. The flow cytometry studies were done on 20 new KD patients, not previously reported on, whereas the cloning and sequencing of TCK ~ chain junctional regions were carried out on three Vfl2 amplified gene products obtained from three patients previously studied (9) . The latter three samples were selected for their particularly high level of VB2 expression (see below). Acute KD was defined by the diagnostic guidelines of the American Heart Association (10) and required that patients have no clinical and/or laboratory evidence of any other disease known to mimic KD. Blood was drawn before intravenous gamma globulin treatment in 18 patients with acute KD (within 10 d of the onset of fever) and after 30 d of the onset of fever in 10 patients (convalescent KD). We were able to obtain eight paired samples from the acute and convalescent phase of KD. 13 children and 8 adults were studied as healthy controls. Because the highest prevalence of KD is seen in Japan, and 6 out of 23 of the KD patients in our study were Japanese, we included six Japanese children and four Japanese adults in the healthy control group although our previous study showed that ethnic differences did not affect the TCK repertoire (9) . Informed consent was obtained from either the patient or the child's parents according to the guidelines of each medical center.
Lymphocyte Isolation and Culture. PBMC were isolated from heparinized blood by Ficoll-Hypaque density gradient centrifugation. PBMC were then analyzed either fresh or after culture with anti-CD3 and IL-2 to increase the production of functional TCR mlLNA for the TCIL VB analysis by PCR. In these experiments, PBMC were stimulated for 3 d at 37~ with anti-CD3 (20 ng/ml; Ortho Diagnostic Systems Inc., Westwood, MA), washed and expanded for 1 d in Ib2 as previously described (8, 9) . Previous studies with cells from normal individuals have demonstrated that anti-CD3 stimulation for 3 d does not selectively expand a particular V/3 population compared with freshly isolated PBMC (8, 9) .
Assessment of TCR V• Expression.
We used two methods to assess the TCR VB repertoire in peripheral blood. The first method utilized two-color immunofluorescence with biotinylated mAbs directed at four different V~ segments as previously described (11) . These included mAbs directed to Vfl2 (clone E22E7; Immunotech, Marseille, France), VB5.1 (clone LC4; T Cell Science, Cambridge, MA). V/~8.1;8.2 (clone MX6, [12] ), and V/312 (clone $511, [13] ), followed by incubation with streptavidin-PE (1:100) (Fisher Biotech, Pittsburgh, PA) and FITC-conjugated anti-CD3, anti-CD4, or anti-CD8 (Olympus Corp., Lake Success, NY). The anti-V32 antibody (routine IgM) was produced by using spleen cells from mice immunized with a murine TCR 3 chain-defirient hybridoma that had been transfected with a human-routine chimeric hV32-hDJflhC3-mCfl DNA construct (Romagne, F., L. Besnardeau, and B. Malissen, manuscript in preparation). Its specificity was confirmed by showing that it stained T cell hybridomas expressing hVB2, but not hybridomas expressing other human V/~s, as well as human T cell clones expressing VB2, but not human T cell clones expressing members of other VB families. The V~ expression of the latter T cell hybridomas and clones were independently determined by PCR (14) . In accord with quantitative PCR results (14) , the blast population after in vitro stimulation with TSST-1 was greatly enriched for cells staining with E22E7 (>50% vs >10% staining in the starting population), whereas cells staining with this mAb were excluded from blasts after stimulation with staphylococcal enterotoxin B (SEB). Fluorescence intensity was analyzed with an Epics Profile Cytofluorograph (Coulter Electronics Inc., Hialeah, FL). Both freshly isolated and cultured PBMC were analyzed. Forward angle and 90 ~ light-scatter patterns were used to gate on lymphocytes or blast cells in each case. The percentage of T cells bearing each TCR VB phenotype was expressed as a percentage of total T (CD3 +) cells.
The second method utilized a quantitative PCR method to estimate the proportion of T cells expressing particular VB gene segments (14) . In these experiments, 2/zg of total RNA prepared from anti-CD3-stimulated cells was used for the synthesis of first-strand cDNA. For each PCR, TCk 3 and a chain cDNAs were coamplified using oligonucleotide primers specific for V~2 or Vfll2 and an oligomer from the downstream/3 chain C region (C~ primer) as one pair, and two Ca primers as the other pair. The sequences of the specific primers used and details of the PCIL have been published (14) . The amount of product was quantitated by incorporation of 32p end-labeled 3' primers added to the reactions (~106 cpm each). The data were expressed as amount of V3 product over the amount of Ca product, or VjffCa ratio, for each Vfl. The PCR technique employed 23 cycles of amplification. In separate experiments, we analyzed the quantitative nature of the PCIL technique by examining input Vfl RNA versus amount of amplified PCR product obtained. Over the range of V~ values obtained in this study, there was a direct linear correlation between the ratio of V3 PCR product amplified and the amount of mRNA analyzed.
Cloning and Sequencing of TCR ,8 Chain Junctional
Regions. 10 /xg of total RNA was used to synthesize cDNA followed by PC1L with a Vfl2 or Vfl8.1 primer and a 3' C3 primer. The sequences of the primers were 5'-GGGAATTCTCATCAACCATGCAAG-CCTGACCT-3' for Vfl2, 5'-GGGAATTCATTTACTTTAACAA-CAACGTTCCG-3' for Vfl8.1, and 5'-GGGATCCTTCTGATGG-CTCAAACAC-3' for C~. The Vfl and Cfl primers carried EcoRI or BamHI sites, respectively (underlined). After 22 cycles of PCR, amplified/3 chain fragments were extracted with phenol-chloroform and precipitated with ethanol. Purified fragments were then digested with EcoRI and BamHI, ligated into plasmid pTZ18R (Pharmacia LKB Biotechnology Inc., Piscataway, NJ) and cloned. Doublestranded plasmid DNAs were prepared by alkali-lysis method and acid phenol extraction and were sequenced by Sequenase Ver2.0 kit (US Biochemical, Cleveland, OH) following the manufacturer's recommendations (15) .
Results and Discussion
In a previous study using a quantitative PCR technique and 22 different V~/-spedfic primers, we reported markedly increased expression of VB2 and less so of VB8.1 gene segments by peripheral blood T cells from acute KD patients (9) . A mAb to VB2 was not available at the time of those analyses, but has since been generated. In the following experiments, we analyzed TCK V32 expression using a VB2-specific mAb and flow cytometry and compared these data to results obtained with the quantitative PCR technique on samples from a new group of KD patients. All cells in these experiments were initially stimulated with anti-CD3. As shown in Fig. 1 , the mean percentage of V/~2 + T cells in 13 acute KD patients was significantly higher than the control group of 13 healthy children (mean _+ SEM = 8.1 + 0.5% for acute KD vs. 6.4 +_ 0.3% for healthy children; p = 0.01 by two tailed unpaired Student's t test), or eight healthy adults (5.7 _+ 0.5% for healthy adults; p = 0.007). In contrast, there was no significant difference seen in the percentages of T cells bearing VJ55.1 between patients (2.9 + 0.2%) and controls (2.6 + 0.3%; p = 0.22). The mean percentage of V~2 + T cells in acute KD patients was also increased compared with convalescent KD patients (6.2 _ 0.6%; p = 0.03). A decrease in V/~2 § T cells after the acute phase was also apparent in the eight patients followed serially (Fig. 1) . Only one patient maintained an increased percentage of VB2 + T cells in convalescence. It is interesting that this patient developed mitral valve insufficiency as a complication of her KD. None of the other patients studied in convalescence showed signs of cardiac involvement.
We also analyzed the ratio of V~ cDNA to Cc~ cDNA amplified by PCR using the same PBMC that were studied by immunofluorescence analysis. We analyzed V/~2/Ccz and VB12/C(x ratios of samples from both acute and convalescent KD patients and control subjects. To obtain a wide range for V~12 expression, some of the control PBMC were also stimulated with SEB (11) and analyzed by both immunofluorescence and PCR. The VB/Cot ratios obtained by PCR were compared with the percentages of T cells bearing a particular VB as determined by immunofluorescence. A linear correlation was found between these two methods of V/~ analysis (Fig. 2) . In healthy controls and convalescent KD pa- The VB2/C~x ratio was 0.26 for donor KD3, 0.29 for KD4, and 0.46 for donor KD5 as compared to a mean VB2/Ccz ratio of 0.10 for normals. The VBS/C~x ratio was 0.14 for KD3 as compared to a mean VBS/Ccx ratio of 0.07 for normals. Three clones that contained stop codons and two KD4 clones, one containing J31.4 and the other J/~2.7, that could not be defined in the junctional region, are not shown.
tients, the slopes of the regression lines for V32 and V312 had similar values of 0.01 and 0.02, respectively, indicating that the VB fragments were amplified by PCR with similar ef~dencies. It is interesting that in acute KD patients, a significantly steeper slope for VB2 (0.06; p = 0.003 by analysis of covariance) was seen. These data suggest that in addition to an increased percentage of V/~2 + T cells, there was proportionately greater V32 mRNA expressed per cell during acute KD. It is surprising that this increased expression per cell appears to be maintained despite in vitro activation with anti-CD3 and 11.-2.
To determine whether the in vitro anti-CD3 activation had an effect on the V/3 analyses, and to determine what T cell subsets were expanded in KD, freshly isolated PBMC taken from nine patients with acute KD and 11 controls were assessed for expression of V/32, 5.1, or 8.1 on CD3, CD4, and CD8 T cells by direct two-color immunofluorescence and flow cytometry (Fig. 3 ). In the total T cell population, V/32 + and V/38.1 + cells were significantly increased in patients with acute KD (p = 0.009 and 0.01, respectively) but V/35.1 + cells were not increased (p = 0.9). These data are consistent with the above data and our previous report (9) . Although V/32 § and V/38.1 + T calls were increased in both CD4 and CD8 T cells in patients, V/32 expression in only the CD4 population was significantly different (p = 0.03) between patients and controls. Superantigens stimulate T cells almost solely through the V/3 portion of the TCK and therefore induce an expansion of T cells mostly independent of their TCRjunctional regions. This is markedly different from T cells activated by most conventional peptide antigens which frequently results in an expansion of only a subset of V3-expressing cells with limited TCK junctional diversity. To determine whether V/32 + and V/38 § T cells were expanded in a polyclonal vs. oligoclonal manner in acute KD, we analyzed the sequence of random eDNA clones containing PCR-amplified V/32 and V/38 segments ( Table 1) .
The sensitivity of our analysis for clonotypic expansion was initially determined by mixing normal PBMC with V/38.1 + Jurkat cells. Analysis of TCR V/38.1 usage by flow cytometry showed that the addition of Jurkat ceils increased the percentage of CD3+/V/38 + cells from 2.4% in the original PBMC sample to 4.8%. The V/38/CoL ratio assessed by PCK also increased from a baseline of 0.09 to 0.14, which was equal to the V/38/Cot ratio of acute KD sample no. 3 examined simultaneously (Table 1) . Sequencing random eDNA clones containing PCR-amplified V/38.1 gene segments from the Jurkat-PBMC control mixture showed that 4 out of 10 eDNA clones (40%) encoded the same junctional sequence as Jurkat clones, proportional to the immunofluorescence data. These data indicated that our assay was sufficiently sensitive to detect oligoclonal expansions among samples with elevated V3/Co~ ratios over the range of KD samples studied.
45 V/32 eDNA clones derived from three patients with acute KD who had a two-to threefold increase in V/32 gene expression, and 17 V/38.1 eDNA clones from a patient with a 60% increase in V/38 gene expression were sequenced. If acute KD were associated with a clonotypic expansion of V/32 + and V/38 + T cells, a significant percentage of the clones could have been expected to have identical junctional sequences. However, as shown in Table 1 , none of the V/32 or V/38 clones had the same junctional sequence, and considerable diversity among the sequences within each individual was apparent. The CDK3 regions varied greatly in terms of residue number and sequence. The high proportion of charged residues in the junctional regions is similar to other T cell populations analyzed (16, 17) , and a conserved motif is not apparent. In some sequence sets, preferential usage of certain J/3s (e.g., J/32.7 in patient KDS) may be suggested. However, this may represent a sampling artifact and similar results have been seen with normal samples (16) .
In view of the selective expansion of V/32 + and V/38 + T cells in acute KD (9) , the extensive/3 chain junctional diversity suggests that these V/3s play a dominant role in recognition. This type of recognition is not characteristic of responses to most peptide antigens. A complex response to multiple antigens or epitopes also seems unlikely since multiple V/3 regions would be expected to be involved. A dominant role for V/3 (vs. CDK3 region) has been occasionally observed for T cell responses to particular peptide-MHC complexes (17) (18) (19) , including a human CD4 + T call response to a tetanus toxin-derived peptide being presented by different class II MHC molecules (17) . However, the apparent frequency of responding cells in the circulation of acute KD patients (>1 in 50) seems out-of-proportion to that expected for a response to a conventional antigen. Together, this high frequency of response and the prominent role for V/3 appear to be more consistent with the hypothesis that T cell activation during the acute phase of KD is mediated by a superantigen. Verification that KD is caused by a superantigen awaits identification of the etiologic agent.
The mechanism by which marked T cell activation might contribute to the clinical manifestations of KD is unclear. Bacterial superantigens such as staphylococcal enterotoxins and streptococcal erythrogenic toxins (SPEs) can cause massive T cell stimulation and cytokine release, including potent induction of Ibl and TNF. In recent studies of a murine modal of toxic shock syndrome, the in vivo release of TNF-oe was shown to be dependent on superantigen stimulation of T cells (20, 21) . As in toxic shock syndrome, T cell stimulation may be critical to cytokine release in acute KD. The production of increased circulating levels of Ibl and TNF as well as other cytokines, e.g., IL-6, have been reported to occur during the acute phase of KD (5) . These cytokines play a critical role in the induction of inflammatory and thrombotic responses (6) . In the case of acute KD, the secretion of Ibl and TNF is associated with the expression of leukocyte adhesion molecules which localize inflammatory cells to the vascular wall and are thought to play an important role in the pathogenesis of vasculitis in this disease (22) .
The etiologic agent which causes KD is currently unknown. Nevertheless, it is widely believed that KD is caused by an infectious agent because of the acute self-limited nature of this disease, geographical clustering of outbreaks, the clinical symptoms of fever and exanthem mimicking other infectious diseases, and the unique susceptibility of young children, suggesting that humoral immunity to the KD agent develops early in life (23) . Our present results may provide a new avenue of investigation into the potential etiology of this fascinating disease.
